The use of psychotropic drugs is important in Morocco related to the large amount of sufferers by psychiatric disorders, according to a survey of the Moroccan Ministry of Health (2010). A prevalence of 26.5% of depressive disorders, and 9% for generalized anxiety disorder, and 5.6% of psychotic disorders was recorded within population, hence the importance to describe the use and assess the prevalence of psychotropic and socio-economic factors was associated with their use. Our research is a retrospective study, carried out between February 2010-December 2013, holding a sample of 5618 patients aged between 1 and 90 years old. The study is concerned with drawing social and clinical data from patients' records. The different classes of psychotropic drugs prescribed to patients in the psychiatric department Moulay El Hassan Hospital, vary between antidepressants (36%), antipsychotics (32%), anxiolytics (10%), anti-epileptics (9%), the class of diverse "sulpiride" (7%), anti-parkinsonian (6%), and hypnotics were prescribed in rare cases. The relationship between socio-economic factors and the take of a psychotropic treatment was very strong in Morocco. In contrast, the patients support showed by close families and the health care staff remain a challenge for Moroccan population.
the Office of the French Language as: "A chemical substance of natural or artificial origin, which is likely to modify mental activity and whose main action gets exerted at central nervous system, and indirectly, but regularly on the psyche."
This definition is accompanied with the following note: "Psychotropic drugs cover a wide variety of agents including those that modify the behavior by direct or indirect action on the central nervous system or by peripheral action." We also talk about psychotropic drugs, as those "used primarily for their effects on consciousness, mood, and perception of internal and external environments" [1] .
In Morocco, a survey conducted by the CNOPS (National Fund for social
Prediction and Security bodies) shows a slight female predominance. Psychotropic drugs were prescribed in half of the cases between 40 and 60 years old.
Generalists are the leading prescribers with (27.2%), followed by psychiatrists (19%). Anxiolytics are the most frequently prescribed (44.9%) of psychotropic drugs, followed by antipsychotics (25.2%) and antidepressants (18.7%), and finally hypnotics with (3%) of cases. Women consumed more anxiolytics and antidepressants than men [2] . Moreover, psychotropics have witnessed a considerable evolution during recent years. They have got to approach the neurobiological and psychopharmacology slopes of mental illness. Throughout the years, research has led to improve modes of action with more specificity, and better tolerance. Hence the emergence of new generations of psychotropic drugs has been given birth. However, medically speaking, prescribing psychotropic is not going without causing some problems in terms of indication, dosage or treatment time duration [3] .
Our study's objective is to highlight the different classes of psychotropic drugs prescribed by psychiatrists, and the factors influencing the use or consumption of psychotropic drugs in the population.
Method
Our research is a retrospective study, conducted between February 2010 up to December 2013. About 5618 cases of study, aged between 1 and 90 years old, living in The Gharb-Cherarda Beni Hssen Region and consultant at The Psychiatric Health Center at "Moulay El Hassan Hospital". Mental Health Department, located in the city of Kenitra (North west of Morocco). The study is concerned with raising social and clinical data from patients' records. These forms were filled out by psychiatrists. The variables used in this research were: sex, age, origin, household size, Social rank among siblings, parents, marital status, educational level, occupation, and income.
Psychotropic medicines prescribed to patients were noted from the records of patients who make use of psychotropic drugs delivered in each consultation.
The list of psychotropic drugs has been enumerated based on the International Classification of (Delay and Deniker) as well as (Vidal, 2012 ). However, it should be revealed that some products may be prescribed for their muscle relaxant effects such as: vitamins, Oligo-elements such as "Magnesium" and Anti-histamines, have not been considered as psychotropic drugs in our work except the active ingredient "Sulpiride" which is classified in the diverse family which was taken into account, thanks to its psychostimulant effect.
Statistical analysis was based on a prevalence calculation of the use of psychotropic drugs in the population, and secondly, prevalence calculation of socioeconomic variables.
Results

Presentation of Psychotropic Drugs Classes
The different categories of psychotropic drugs, prescribed to patients in the psychiatric department at Moulay El Hassan Hospital in Kenitra city vary between antidepressants (36%), neuroleptic (32%), whereas anxiolytics represent (10%), while anti-epileptics were prescribed with an average rate of (9%). In contrast, the diverse class were prescribed by (7%) of cases, while anti-parkinsonians were by an average rate of (6%) and hypnotics were prescribed in rare cases, in a negligible prevalence (Figure 1 ).
Distribution of Psychotropic Consumption according to Age
Categories The use of neuroleptics was higher among the highest age categories between (80 -100) years old. Prevalence were at an average rate of (85.45%) and also were higher in young patients (20 -40) years, in which the prevalence were (53.22%), and tend to decrease among the remaining age groups between (60 -80) years,
were by (50.92%), for ages between (0 -20) years, were by (49.33%), and regarding the age categories between (40 -60) years, the prevalence were by (46.79%).
However, the consumption of antidepressants was higher in patients aged between (40 -60) years, the prevalence were by (23.02%) and by (21.73%) for pa- Figure 1 . Presentation of psychotropic drugs classes. It was noticed that women (68.06%) were higher consumers of diverse drugs than males (31.94%). The results have shown that there is a highly significant correlation between sex gender and consumption of psychotropic drugs, at p < 0.0001.
Distribution of Psychotropic Consumption according to Socio-Economic
The prevalence of neuroleptic consumptive use among patients living in urban areas was (54.96%). Whereas with patients living in rural areas, the prevalence was about (40.98%). In fact, among the temporary users were about (4.06%). Moreover, the prevalence of antidepressant users was higher among patients living in urban areas, followed by patients living in rural areas. Prevalence were respectively by (71.88%) and (24.52%). On the other hand, Prevalence among momentary-user patients was lower than (3.61%). However, the take of anxiolytics by patients living in rural areas and those living in urban areas was respectively at the rate of (47.56%) and (43.97%). But, the prevalence was lower with momentary-user patients at the rate of (8.47%). In contrast, the prevalence of consumption of hypnotics was much higher with patients living in the urban area at the rate of (100%), whereas the prevalence of their use by patients living in rural areas, and by temporary-user patients was negligible. While the prevalence of consumption of anti-epileptics with patients living in rural areas, were at the rate of (54.89%), and were at the rate of (41.73%) with patients living in urban areas. While with momentary-user patients were lower at the rate of (3.38%). In fact the prevalence of the take of anti-parkinsonian with patients living in the urban area were higher (56.28%), and tends to decrease among those living in rural areas (41.62%) and among momentary-user patients (2.09%). However, the prevalence of drug use of diverse family with patients living in rural areas was at the rate of (58.79%), and with patients living in urban areas was at the rate of (35.43%). whereas with temporary-user patients were lower at the rate of (5.78%). The results have shown that there is a significant correlation between the origin and consumption of psychotropic drugs, at p < 0.01.
Neuroleptics consumption with patients classified in the 2 nd and 3 rd position among siblings, is defined by higher prevalence (33.80%) and (33.27%). While the prevalence of neuroleptics taken by patients classified into the first row by a rate of (26.78%), and for patients classified in the fourth row were at a rate of (6.15%). Moreover, the prevalence of antidepressant users were higher among patients classified on the 2 nd and 3 rd row, and were at the rate of (34.51%) and The prevalence of neuroleptics use with patients in large households was at the rate of (36.00%). Whereas with patients in average household was at the rate of (34.45%), with those of small households was at the rate of (29.55%). Moreover, the prevalence of antidepressant were respectively higher among average as well as small households was at the rate of (36.99%) and (35.04%), but it was lower among patients living in large households (27.97%). However, the take of anxiolytics by patients of respectively average as well as small households was at the rate of (37.25%) and (36.82%), but it was lower among patients living in large households at the rate of (25.93%). But the consumption of hypnotics was much higher with patients living in small household (91.11%), while the prevalence of their use with patients of average households was much weaker at the rate of (8.89%), but was negligible with patients in large households. The prevalence of consumption with patients of average households was at the rate of (37.36%) and was at the rate of (31.32%) higher than with patients living in small households or those in large families. In fact, the take of anti-parkinsonian by patients of average household was higher at the rate of (67.43%) and tends to decrease respectively among those in large households as well as small households at the rate of (18.89%) and (13.67%). However, the consumption of drugs of diverse families with patients living respectively in average as well as small households was at the rate of (36.29%) and (33.28%), whereas with patients of large households was at the rate of (30.43%). The results have shown that there is no correlation between household size and consumption of psychotropic drugs.
Single patients use neuroleptics at a higher frequency. Prevalence were at the rate of (54.53%), while the prevalence among married patients was at the rate of (37.55%), and tends to decrease respectively with divorced patients and widows at the rate of (4.71%) and (3.21%). In contrast, the consumption of antidepressants was higher among married patients. The prevalence were at the rate of (59.32%), and single patients were at the rate of (29.68%), but they were respectively lower for widows and divorced patients at the rate of (5.67%) and (5.33%).
While the take of anxiolytics by married patients was higher at the rate of (59.40%), whereas their use with single patients was at the rate of (27.78%). In fact, the prevalence were respectively lower with widows and divorced patients at the rate of (6.62%) and (6.20%). However, the prevalence of consumption of hypnotics was much higher among married patients at the rate of (80.00%), whereas among widows and widows patients were at the rate of (20.00%), whereas that was insignificant among single and divorced patients. In contrast, the prevalence of consumption of antiepileptic drugs with single patients was much
higher at the rate of (63.59%), while among married patients was at the rate of (30.21%), and were respectively lower regarding widows and divorced patients at the rate of (3.29%) and (2.91%). Furthermore, the take of anti-parkinsonian by single patients was far higher by (92.44%) but it was lower among married patients as well as divorced and widows. The prevalence was respectively at the rate of (6.20%), (0.77%) and (0.59%). However, the consumption of drugs of diverse family was higher among married patients. The prevalence was at the rate of (61.20%), and single patients were at the rate of (27.76%). On the other hand, they were respectively lower concerning divorced and widows patients with an amount of (6.02%) and (5.02%). The results have shown that there is a highly significant correlation between marital status and the consumption of psychotropic drugs, at p < 0.0001.
Patients whose fathers are still alive consume more neuroleptics than those whose fathers are dead. In fact, the prevalence of their consumption was higher with patients with living fathers at a rate of (60.78%) and lower among those with died fathers at a rate of (39.22%). Regarding the consumption of antidepressants, prevalence were higher in both cases and were respectively at the rate of (55.59%) and (44.41%) regarding patients with living fathers and fathers who died. In contrast, the prevalence of consumption of anxiolytics was at the rate of (56.41%) with patients whose fathers are alive, and by (43.59%) among patients whose fathers are dead. Moreover, the prevalence of consumption of hypnotics was too higher with patients with dead fathers by (80.00%), whereas patients with living fathers were by (20.00%). However, the prevalence of consumption of antiepileptic drugs by patients with living fathers were very higher at a rate of (65.78%), but it was lower in patients whose fathers are dead at a rate of (34.22%). However, the take of anti-parkinsonian by patients with living fathers were at the rate of (60.48%), and those with dead fathers were at the rate of (39.52%). While the consumption of drugs of diverse family was also much higher in patients with living fathers (53.51%) than those with dead fathers (46.49%).The results have shown that there is a significant correlation between the presence of the father and the consumption of psychotropic drugs, at p < 0.01.
The prevalence of the use of neuroleptics was up in patients with living mothers at a rate of (76.60%) and lower in those whose mothers died (23.40%). In contrast, the prevalence of consumption of antidepressants in patients with living mothers was much higher at a rate of (89.19%), while it was lower in those whose mothers died by (10.81%). Yet, the prevalence of consumption of anxiolytics was at the rate of (71.26%) among patients with living mothers and (28.74%) in those whose mothers died. However, the prevalence of consumption of hypnotics was higher among patients with living mothers by a rate of (60.00%), while those whose mothers died the prevalence were at the rate of (40.00%).
Moreover, the prevalence of consumption of anti-épileptics among patients with living mothers was very much higher by (80.66%), but it was lower among those whose mothers died by a different rate of (19.34%). In fact, the take of anti-parkinsonian by patients with living mothers was very higher at a rate of (76.20%) and was lower among those whose mothers died by a rate of (23.80%).
Still, the prevalence of drug use typed as diverse family was higher among patients with living mothers at a rate of (71.40%), and it was lower in those whose mothers died by a rate of (28.60%). The results have shown that there is a significant correlation between the presence of the mother and the consumption of psychotropic drugs, at p < 0.01 (Table 1) . 
Distribution of Psychotropic Consumption according to Level of Education
At this study, we notice that the prevalence of neuroleptics use by illiterate patients were at the rate of (47.38%), whereas by those who have a primary or secondary level of education, the prevalence were at the rate of (44.03%), but among patients with higher level of education the prevalence were lower at the rate of (8.59%). In contrast, the consumption of antidepressants were higher with illiterate patients in that the prevalence were at the rate of (58.38%), and those with a primary or secondary level of education the prevalence were at the rate of (34.72%), but they were lower with patients with higher level of education by a rate of (6.90%). The prevalence of anxiolytics consumption was much higher in illiterate patients and those with a primary or secondary level of education. The prevalence was respectively at a rate of (57.37%) and (36.32%), while the proportion with patients with higher level of education were lower than (6.30%). Moreover, the prevalence of consumption of hypnotics was far higher with patients who have a primary or secondary level of education by a rate of (80.00%), whereas illiterate patients were at a rate of (20.00%) yet, it was not among patients with higher level of education. However, the prevalence of consumption of antiepileptic drugs among illiterate patients were much higher than (51.21%), and (43.82%) among those with a primary or secondary level of education. by contrast, they were lower with patients with a higher educational level at a rate of (4.97%). In effect, the take of anti-parkinsonian by patients with primary or secondary level of education and illiterate patients were higher in that prevalence were respectively at the rate of (47.60%) and (43.89%), whereas with patients with higher level of education the prevalence was lower than (8.52%). Still, the consumption of drugs classified as diverse family was higher with patients with a primary or secondary level of education in that the prevalence were at the rate of (65.61%), whereas with illiterate patients were at a rate of (29.72%), but for patients with a higher educational level, the prevalence was lower at the rate of (4. 
Distribution of Psychotropic Consumption according to the Occupation
At this study, we notice that the prevalence of neuroleptics use was higher among inactive or unemployed patients at a rate of (79.20%), while in active patients were at a rate of (19.96%) and among those who were retired by (0.84%).
In contrast, the prevalence of antidepressant use was higher among inactive or unemployed patients at a rate of (81.20%), and tends to decrease among active patients and retired in which the prevalence were respectively at the rate of (17.77%) and (1.03%). In contrast, the prevalence of consumption of anxiolytics was by (80.34%) in inactive or unemployed patients whereas among active it was at the rate of (18.70%), and among retired patients was at the rate of (0.96%).
Moreover, the prevalence of consumption of hypnotics was higher among active patients at a rate of (60.00%); that is lower by (20.00%) than among patients with inactive or retired patients. However, the prevalence of use of ant-iepileptic drugs was higher in inactive or unemployed patients at a rate of (85.66%), whereas in active patients it was at the rate of (14.10%). Patients and pensioners were at a rate of (0.23%). In fact, the prevalence of anti-parkinsonions consumption was at the rate of (78.17%) in inactive or unemployed patients; whereas, in active patients was by (21.18%) and retired patients was by (0.66%). However, the prevalence of drug use typed as diverse family was higher among inactive or unemployed patients by a rate of (79.43%); whereas, in active patients was at the rate of (19.57%), and retired patients was lower by (1.00%). The results have shown that there is a highly significant correlation between the occupation and the consumption of psychotropic drugs, at p < 0.001, r = 0.10 ( Figure 4 ).
Distribution of Psychotropic Consumption according to the Income
The prevalence of neuroleptics use was higher among patients who have no income. The average rate was (79.27%), whereas in those with a regular income,
A: Active, R: Retired, I: inactive or unemployed. the rate was lower than (20.73% ). Yet, the prevalence of antidepressant use was higher in patients who do not have income (81.14%), and was at a rate of (18.86%) among patients with a regular income. In fact, the prevalence of consumption of anxiolytics was at the rate of (80.13%) in patients who have no income, while in those with a regular income was at an average rate of (19.87%).
Moreover, the prevalence of consumption of hypnotics was higher among patients with a steady income at an average rate of (80.00%). By contrast, it was lower in patients who have no income at an average rate of (20.00%). Despite the fact, the prevalence of the use of antiepileptic drugs was comparatively much higher among patients who have no income at an average rate of (86.94%); whereas their use in patients with a regular income was lower at a rate of (13.06%).
Regarding the consumption of Anti-Parkinsonism, the prevalence was at the rate of (78.38%) among patients who have no income whereas in those with a steady income, it was about (21.62%). In contrast, the prevalence of drug use of the diverse families was higher in patients who do not have income at an average rate of (79.26%) comparatively with those with a regular income in which the prevalence was lower at a rate of (20.74 %). The results have shown that there is a highly significant correlation between income and consumption of psychotropic drugs, at p < 0.001, r = 0.4 ( Figure 5 ).
Discussion
The analysis of these data shows that the use of psychotropic drugs was comparatively higher among women than men. This difference between sex gender is also found in all epidemiological studies in France [5] We noticed a predominance of hypnotics, neuroleptics, antidepressants and anxiolytics consumption among those classified in the 2 nd , or 3 rd rank in the siblings. However, the majority of patients have one or both parents dead and living in hard socio-economic conditions. This result is consistent with several international studies [28] [29] [30] . Furthermore, we discern a higher consumption of psychotropic drugs among single individuals and married, and among those divorced or widowers. In fact, in the same population, we notice a higher consumption of psychotropic drugs among illiterate individuals, and those with a primary or secondary level of education. While the use of psychotropic remains lower among individuals with higher level of education. These results can be explained by the fact of being in a family whose socio-economic situation is difficult, living alone or with lack of social support from the surrounding social background, and to be unemployed, inactive and without a single income.
However, these socio-economic factors were strongly associated with the presence of psychological disorders, and need to be supported by psychological treatments prescribed by a medical expert. In our study it is a Psychiatrist. This result is also found in several international studies [24] [31].
Conclusion
Our study shows that the relationship between socio-economic factors such as "sex, age, origin, household size, rank among siblings, parents, marital status, educational level, occupation, and income," and the take of psychotropic medicines was much stronger in Morocco. However, to reduce the higher consumption of antidepressants, antipsychotics, anxiolytics and hypnotics, we must solve the socio-economic problems, which are responsible for the cause of psychic disorders within Moroccan population.
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